Bromhexine Hydrochloride, Sulfamethoxazole, Trimethoprim — Drug Intelligence | 14 EU Trials

Filter these 14 trials by condition, phase, country and more.

Open in Search →

14 Registered trials

5 Recruiting

1 Completed trials

11 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 5 Phase II: 3 Phase I/II: 1 Phase IV: 5

Indications tested

Antibiotic level therapeutic 1 Glioblastoma 1 B-cell lymphoma refractory 1 B-cell lymphoma recurrent 1 Multiple sclerosis 1 B-cell lymphoma 1 Implant site infection 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 4 Centre Hospitalier Regional Universitaire De Tours 1 Centre Hospitalier Universitaire De Nantes 1 Debiopharm International S.A. 1 Instituto De Investigacion Marques De Valdecilla 1 Miltenyi Biomedicine GmbH 1 Region Midtjylland 1 Region Uppsala 1 Tan Tock Seng Hospital Pte. Ltd. 1 Uppsala Universitet 1 Vaestra Goetalandsregionen 1

All trials

14 total

PROSTABACT : Relevance of the treatment with antibiotics before endoscopic surgery of lower urinary symptoms related to prostate hypertrophy… Not authorised

2023-510191-31-00 Phase III 1 country Centre Hospitalier Regional Universitaire De Tours
DALY II USA/MB-CART2019.1 for DLBCL Pending

2023-508508-39-01 Phase II 2 countries Miltenyi Biomedicine GmbH
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in… Pending

2024-518350-17-00 Phase IV 1 country Vaestra Goetalandsregionen
3-day intravenous antibiotic treatment versus 3-day intravenous followed by 7-day oral antibiotic treatment for acute pyelonephritis in chil… Pending

2024-518930-10-00 Phase III 1 country Assistance Publique Hopitaux De Paris
HiHat trial Pending

2024-519700-28-01 Phase II 1 country Region Uppsala
Optimal Duration of Antibiotic Therapy in Drained Pyogenic Liver Abscess: 3 weeks versus 6 weeks, a non-inferiority trial Pending

2025-520940-14-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiot… Pending

2025-521571-30-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Evaluation of the efficacy of treatment with autovaccines vs antibiotic treatment in subjects with hip or knee prosthesis infections. Recruiting

2024-520226-10-00 Phase III 1 country Instituto De Investigacion Marques De Valdecilla
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Phase IV 1 country Region Midtjylland
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Study of Debio 0123 in Combination with Temozolomide in Adult Participants with Recurrent or Progressive Glioblastoma and of Debio 0123 in… Recruiting

2022-502156-31-00 Phase I/II 1 country Debiopharm International S.A.
Comparison of continuing intravenous antibiotic therapy with switching to oral antibiotics in clinically stable patients with blood infectio… Ended

2024-517308-13-00 Phase IV 3 countries Tan Tock Seng Hospital Pte. Ltd.

Showing 1–14 of 14 trials

← All drugs A–Z